Alison S. Long

Insider Reports History

Location
Kaleido Biosciences, Inc., 65 Hayden Avenue, Lexington, MA
Signature
/s/ Kamran Alam, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Alison S. Long:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Taysha Gene Therapies, Inc. Director Common Stock 106K $318K $3.00 Jun 2, 2025 Direct
Kaleido Biosciences, Inc. Chief Medical Officer Stock Option (Right to Buy) 300K Dec 15, 2021 Direct
Kaleido Biosciences, Inc. Chief Medical Officer Restricted Stock Units 125K Jan 14, 2022 Direct
Taysha Gene Therapies, Inc. Director Stock Option (right to buy) 113K Jun 2, 2025 Direct

Insider Reports Filed by Alison S. Long

Symbol Company Period Transactions Value $ Form Type Date Filed Role
TSHA Taysha Gene Therapies, Inc. Jun 2, 2025 2 $0 4 Jun 4, 2025 Director
TSHA Taysha Gene Therapies, Inc. May 29, 2024 2 $0 4 May 31, 2024 Director
TSHA Taysha Gene Therapies, Inc. Nov 1, 2023 1 $0 4 Nov 3, 2023 Director
TSHA Taysha Gene Therapies, Inc. Nov 1, 2023 0 $0 3 Nov 3, 2023 Director
KLDO Kaleido Biosciences, Inc. Jan 14, 2022 2 $0 4 Jan 18, 2022 Chief Medical Officer
KLDO Kaleido Biosciences, Inc. Dec 15, 2021 2 $0 4 Dec 16, 2021 Chief Medical Officer
KLDO Kaleido Biosciences, Inc. Dec 15, 2021 0 $0 3 Dec 16, 2021 Chief Medical Officer